CoChat

Comprehensive Cost-Utility Analysis of Newborn Screening Strategies

Carroll, Aaron E., Downs, Stephen M. · 2006 · PEDIATRICS

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Inborn errors of metabolism are a significant cause of morbidity and death among children. Inconsistencies in how individual states arrive at screening strategies, however, lead to marked variations in testing between states. OBJECTIVE: To determine the cost-effectiveness of each component test of a multitest newborn screening program, including screening for phenylketonuria, congenital adrenal hyperplasia, congenital hypothyroidism, biotinidase deficiency, maple syrup urine disease, galactosemia, homocystinuria, and medium-chain acyl-CoA dehydrogenase deficiency. METHODS: A decision model was used, with cohort studies, government reports, secondary analyses, and other sources. Discounted costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios were measured. RESULTS: All except 2 screening tests dominated the "no-test" strategy. The 2 exceptions were screening for congenital adrenal hyperplasia, which cost slightly more than $20,000 per QALY gained, and screening for galactosemia, which cost $94,000 per QALY gained. The screening test with the lowest expected cost was tandem mass spectrometry. The results found in our base-case analysis were stable across variations in nearly all variables. In instances in which changes in risks, sequelae, costs, or utilities did affect our results, the variation from base-case estimates was quite large. CONCLUSIONS: Newborn screening seems to be one of the rare health care interventions that is beneficial to patients and, in many cases, cost saving. Over the long term, funding comprehensive newborn screening programs is likely to save money for society.

Overview

Integrity signals

Registry

Crossref · 10.1542/peds.2005-2633h

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 3

  1. Centers for Disease Control and Prevention. Using tandem mass spectrometry for metabolic disease screening among newborns. MMWR Morb Mortal Wkly Rep. 2001;50:1–22. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr5003a1.htm. Accessed May 13, 2004
  2. National Newborn Screening and Genetics Resource Center. Homocystinuria. In: National Newborn Screening Report—2000. Austin, TX: National Newborn Screening and Genetics Resource Center; 2003:1–11. Available at: http://genes-r-us.uthscsa.edu/resources/newborn/00/ch7_complete.pdf. Accessed June 23, 2004
  3. US Congress, Office of Technology Assessment. Data and methods used in OTA's cost-effectiveness analysis of strategies for newborn screening. In: Healthy Children: Investing in the Future. Washington, DC: US Government Printing Office; 1988:236–241. Publication OTA-H-345. Available at: www.wws.princeton.edu/cgi-bin/byteserv.prl/∼ota/disk2/1988/8819/881919.PDF. Accessed June 3, 2004

Cited by

See all 183

Metadata

Authors
Carroll, A. E., & Downs, S. M.
Affiliations
Regenstrief Institute (US)
Venue
PEDIATRICS
Published
2006-05-01
Volume
117
Issue
Supplement_3
Pages
S287-S295
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
OpenAlex
W2147142253
Cited by
165
References
39
Citations by year
2026: 1 · 2025: 3 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 9 · 2020: 13 · 2019: 13 · 2018: 3 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 10 · 2013: 10 · 2012: 5
FWCI
7.29
Type
journal article
Language
en
Open access
closed
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5k23dk067879-02)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK67879-01)
  • Maternal and Child Health Bureau
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
Keywords
newborn screening, cost-effectiveness, inborn errors of metabolism, phenylketonuria, congenital adrenal hyperplasia, congenital hypothyroidism, biotinidase deficiency, maple syrup urine disease, galactosemia, homocystinuria, medium-chain acyl-CoA dehydrogenase deficiency, tandem mass spectrometry, quality-adjusted life years, incremental cost-effectiveness ratio, decision models
MeSH terms
Cost-Benefit Analysis, Decision Support Techniques, Humans, Infant, Newborn, Metabolism, Inborn Errors, Mass Spectrometry, United States, Neonatal Screening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comprehensive Cost-Utility Analysis of Newborn Screening Strategies. https://app.cochat.ai/papers/10.1542/peds.2005-2633h
The paper
Carroll, A. E., & Downs, S. M. (2006). Comprehensive Cost-Utility Analysis of Newborn Screening Strategies. PEDIATRICS. https://doi.org/10.1542/peds.2005-2633h

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.